These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25453423)

  • 1. The use of paralytics in patients with acute respiratory distress syndrome.
    Hraiech S; Dizier S; Papazian L
    Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paralytics in critical care: not always the bad guy.
    Forel JM; Roch A; Papazian L
    Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
    Hua Y; Ou X; Li Q; Zhu T
    PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neuromuscular blockers in ARDS: benefits and risks.
    Hraiech S; Forel JM; Papazian L
    Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.
    Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM
    Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
    Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
    Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Paralysis for the Management of ARDS.
    Grawe ES; Bennett S; Hurford WE
    Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome.
    Arroliga AC; Thompson BT; Ancukiewicz M; Gonzales JP; Guntupalli KK; Park PK; Wiedemann HP; Anzueto A;
    Crit Care Med; 2008 Apr; 36(4):1083-8. PubMed ID: 18401254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
    Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
    Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking agents for acute respiratory distress syndrome.
    Torbic H; Duggal A
    J Crit Care; 2019 Feb; 49():179-184. PubMed ID: 30396789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotopic ossification due to neuromuscular blocking agent in adult respiratory distress syndrome. A case report.
    Zynnurodlu M; Kaymak Karatap G; Sepycy V
    Eur J Phys Rehabil Med; 2008 Mar; 44(1):81-5. PubMed ID: 18385631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.
    Tao W; Yang LQ; Gao J; Shao J
    J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myorelaxants in ARDS patients.
    Hraiech S; Yoshida T; Annane D; Duggal A; Fanelli V; Gacouin A; Heunks L; Jaber S; Sottile PD; Papazian L
    Intensive Care Med; 2020 Dec; 46(12):2357-2372. PubMed ID: 33159530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.